Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R. Riedel M, et al. Among authors: klosterkotter j. World J Biol Psychiatry. 2012 Jan;13(1):30-8. doi: 10.3109/15622975.2011.552633. Epub 2011 May 13. World J Biol Psychiatry. 2012. PMID: 21568628 Clinical Trial.
Prediction of symptom remission in schizophrenia during inpatient treatment.
Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Bottlender R, Strauss A, Möller HJ. Jäger M, et al. Among authors: klosterkotter j. World J Biol Psychiatry. 2009;10(4 Pt 2):426-34. doi: 10.1080/15622970701541054. World J Biol Psychiatry. 2009. PMID: 17853260
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W. Möller HJ, et al. Among authors: klosterkotter j. Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9. Int J Neuropsychopharmacol. 2008. PMID: 18466670 Free article. Clinical Trial.
Internal capsule size associated with outcome in first-episode schizophrenia.
Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W, Riesbeck M, Maier W, Klosterkötter J, Schneider F, Buchkremer G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P. Wobrock T, et al. Among authors: klosterkotter j. Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):278-83. doi: 10.1007/s00406-008-0867-y. Epub 2009 Feb 17. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19224108 Free PMC article.
Attitude towards adherence in patients with schizophrenia at discharge.
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. J Psychiatr Res. 2009 Dec;43(16):1294-301. doi: 10.1016/j.jpsychires.2009.05.003. Epub 2009 Jun 7. J Psychiatr Res. 2009. PMID: 19505697
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. World J Biol Psychiatry. 2010 Aug;11(5):729-38. doi: 10.3109/15622971003690289. World J Biol Psychiatry. 2010. PMID: 20380620
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Engel RR, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. J Clin Psychopharmacol. 2010 Dec;30(6):726-31. doi: 10.1097/jcp.0b013e3181faf39b. J Clin Psychopharmacol. 2010. PMID: 21105273
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?
Schennach-Wolff R, Jäger M, Mayr A, Meyer S, Kühn KU, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Gaebel W, Seemüller F, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. Eur Neuropsychopharmacol. 2011 May;21(5):370-8. doi: 10.1016/j.euroneuro.2010.10.003. Epub 2011 Jan 20. Eur Neuropsychopharmacol. 2011. PMID: 21255982 Clinical Trial.
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. J Psychiatr Res. 2011 Dec;45(12):1639-47. doi: 10.1016/j.jpsychires.2011.07.014. Epub 2011 Aug 20. J Psychiatr Res. 2011. PMID: 21862035
311 results